Sensex
77,264.51 profit arw 330.92 (0.43%)
Nifty
24,175.65 profit arw 84.80 (0.35%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 26-Aug-2026
Corporate News
26-Aug-2026     20:41

Senores Pharmaceuticals to establish subsidiaries in Mexico and Canada for distribution

Senores Pharmaceuticals Limited recently announced several corporate actions, including the appointment of Dr. Viranchi Arvindbhai Shah as a director, who brings extensive experience in the pharmaceutical sector. The company also formally approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), granting 4,72,000 options, representing 1% of fully diluted equity, with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals intends to incorporate a wholly-owned subsidiary in Mexico for pharmaceutical product supply and distribution, and plans to establish a subsidiary in Canada with at least 51% ownership, also for pharmaceutical distribution. Both international ventures will require regulatory approvals and involve cash investments.

INDIAN INDICES

Sensex

77,264.51 330.92 (0.43%)

Nifty

24,175.65 84.80 (0.35%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,584.80 19.05(0.07%)